Planet Green (PLAG) - 2025 Q2 - Quarterly Report
2025-08-14 20:11
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ____________ Commission File Number: 001-34449 PLANET GREEN HOLDINGS CORP. (Exact name of registrant as specified in its charter) (State or other jurisdictio ...
AZIYO BIOLOGICS(AZYO) - 2025 Q2 - Quarterly Results
2025-08-14 20:11
Exhibit 99.1 Conference call today at 5:00 p.m. ET / 2:00 p.m. PT GAITHERSBURG, Md., August 14, 2025 — Elutia Inc. (Nasdaq: ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix technologies, today provided a business update and financial results for the second quarter of 2025. Since full launch in January 2025, EluPro has rapidly established itself as the preferred antibiotic bioenvelope choice in cardiac implantable electronic device procedures, delivering robust revenue growth and expand ...
Elutia(ELUT) - 2025 Q2 - Quarterly Results
2025-08-14 20:11
Exhibit 99.1 · EluPro Momentum: Second quarter 2025 revenue up 49% sequentially. Total BioEnvelope revenue reached $3.5 million, up 33% year-over-year, with EluPro now contributing about two-thirds of total BioEnvelope sales. · Robust Market Access of EluPro: VAC approvals now more than 160 centers, averaging about 12 new approvals monthly; customer base has grown more than 15x since launch. · Strong Clinical Demand: EluPro customers are delivering meaningfully higher value than our legacy BioEnvelope platf ...
New Providence Acquisition Corp III-A(NPAC) - 2025 Q2 - Quarterly Report
2025-08-14 20:11
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-42610 NEW PROVIDENCE ACQUISITION CORP. III | | | Name of each exchange on which | | --- | --- | --- | | Title of each class | Tr ...
New Providence Acquisition Corp III Unit(NPACU) - 2025 Q2 - Quarterly Report
2025-08-14 20:11
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-42610 NEW PROVIDENCE ACQUISITION CORP. III (Exact name of registrant as specified in its charter) Cayman Islands 98-1834924 (Sta ...
GlucoTrack(GCTK) - 2025 Q2 - Quarterly Report
2025-08-14 20:11
For the quarterly period ended June 30, 2025 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 or (Address of principal executive offices) (Zip Code) (201) 842-7715 GLUCOTRACK, INC. (Former name, former address and former fiscal year, if changed since last report) (Registrant's telephone ...
SPAR (SGRP) - 2025 Q2 - Quarterly Report
2025-08-14 20:11
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the first quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from __________ to __________. Commission file number 0-27408 SPAR GROUP, INC. (Exact name of Registrant as specified in its charter) Delawar ...
Venus cept (VERO) - 2025 Q2 - Quarterly Results
2025-08-14 20:11
Exhibit 99.1 Venus Concept Announces Second Quarter 2025 Financial Results TORONTO, August 14, 2025 (GLOBE NEWSWIRE) – Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and six months ended June 30, 2025. Summary of Financial Results & Recent Progress: Management Commentary: "Our second quarter revenue results reflect strong execution in a continued challenging environment," said Rajiv De Silva, Chief ...
M3-Brigade Acquisition V Corp.(MBAV) - 2025 Q2 - Quarterly Report
2025-08-14 20:11
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-42171 M3-BRIGADE ACQUISITION V CORP. (Exact Name of Registrant as Specified in Its Charter) Cayman Islands N/A (State or other jurisdiction ...
M3-Brigade Acquisition V Corp.(MBAVU) - 2025 Q2 - Quarterly Report
2025-08-14 20:11
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-42171 M3-BRIGADE ACQUISITION V CORP. (Exact Name of Registrant as Specified in Its Charter) Cayman Islands N/A (State or other jurisdiction ...